Phase 3 Hearing Loss Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults aged 18 or older who are being seen by NHS ear, nose, throat (ENT) or hearing services for tinnitus (ringing or noise in the ears) that is not caused by a heartbeat sound and is not linked to another underlying condition.
- People who have been experiencing tinnitus for at least 3 months.
- People who have access to a smartphone that can run an app called Oto, and are willing to use it.
- People who are willing and able to sign a written consent form to take part in the trial.
- People whose doctors would normally offer them a treatment called tinnitus retraining therapy (a structured program to help the brain learn to tune out tinnitus sounds) as part of their care.
Who may not be able to join:
- People whose tinnitus has been found to have a specific physical cause, confirmed by an MRI (brain scan).
- People who are currently receiving any other tinnitus treatments at the same time, including hearing aids or implants. (Note: having had tinnitus treatments in the past, such as a talking therapy called CBT, is acceptable.)
- People who do not have a suitable smartphone to download the Oto app, or who feel they would not be able to use it.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +447850592603
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Tinnitus Burden
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.